Oral Bacitracin

A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract Source

  • Tran, Truc T.
  • Palmer, Hannah R.
  • Weimar, Marion R.
  • Arias, Cesar A.
  • Cook, Gregory M.
  • Murray, Barbara E.

  • 1Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston

    2University of Houston College of Pharmacy

    3Department of Pharmacy, Baylor St Luke's Medical Center, Houston, Texas

    4Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand

    5Universidad El Bosque, Bogotá, Colombia

    6Department of Microbiology and Molecular Genetics, University of Texas Health Science Center at Houston

a T. T. T. and H. R. P. contributed equally to this work.

Correspondence: Barbara E. Murray, MD, University of Texas Medical School, 6431 Fannin St, MSB 2.112, Houston, TX 77030 ([email protected]).

Clinical Infectious Diseases 60(11):p 1726-1728, June 01, 2015. | DOI: 10.1093/cid/civ130
Copyright © Copyright Oxford University Press 2015.